The Patent Finder

Compounds, Compositions, and Methods for Preventing Metastasis of Cancer Cells

Eyepoint, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/US2010/020822, filed Jan 12, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,569,348Compounds, Compositions, and Methods for Preventing Metastasis of Cancer Cells
In force
 · High confidence
Eyepoint, Inc.In force
High confidence
US 8,883,832Compounds, Compositions, and Methods for Preventing Metastasis of Cancer Cells
In force
 · High confidence
Eyepoint, Inc.In force
High confidence
US 9,174,950Compounds, Compositions, and Methods for Preventing Metastasis of Cancer Cells
In force
 · High confidence
Eyepoint, Inc.In force
High confidence
US 9,949,956Compounds, Compositions, and Methods for Preventing Metasasis of Cancer Cells
In force
 · High confidence
Eyepoint, Inc.In force
High confidence
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited